Analysts at StockNews.com began coverage on shares of Ayala Pharmaceuticals ( NASDAQ:ADXS – Get Rating ) in a note issued to investors on Sunday. The brokerage set a 'sell' rating on the stock. Ayala Pharmaceuticals Stock Performance About Ayala Pharmaceuticals ( Get Rating ) Advaxis, Inc is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins.

https://www.dailypolitical.com/2023/03/19/ayala-pharmaceuticals-nasdaqadxs-research-coverage-started-at-stocknews-com.html

#dailypolitical